Are you a Knight ADRC affiliated researcher with a news article you would like us to post?
Contact Us
International Alzheimer’s prevention trial in young adults begins (Links to an external site)
WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise
Can a Drug Prevent Alzheimer’s Disease Decades Before It Happens? (Links to an external site)
Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer’s.
Memory Loss Isn’t the Only Sign of Dementia (Links to an external site)
Memory loss is the most well-known symptom of dementia, particularly Alzheimer’s disease. But experts say there are other warning signs that can signal early brain changes — ones that are especially important for types of dementia where forgetfulness is not the primary symptom.
Fighting to Avoid Her Mother’s Fate, for Her Daughters’ Sake (Links to an external site)
New drug targets for Alzheimer’s identified from cerebrospinal fluid (Links to an external site)
Using cerebrospinal fluid (CSF) collected from living patients, a team of researchers at Washington University School of Medicine in St. Louis has for the first time linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer’s genesis and progression. Because these proteins were gathered from CSF, they are a good proxy for activity in the brain, and several of them may be potential targets for therapies.